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LOCALLY D-OPTIMAL DESIGNS BASED ON A CLASS OF
COMPOSED MODELS RESULTED FROM BLENDING
EMAX AND ONE-COMPARTMENT MODELS1
By X. Fang and A. S. Hedayat
University of Illinois, Chicago
A class of nonlinear models combining a pharmacokinetic com-
partmental model and a pharmacodynamic Emax model is intro-
duced. The locally D-optimal (LD) design for a four-parameter com-
posed model is found to be a saturated four-point uniform LD design
with the two boundary points of the design space in the LD design
support. For a five-parameter composed model, a sufficient condition
for the LD design to require the minimum number of sampling time
points is derived. Robust LD designs are also investigated for both
models. It is found that an LD design with k parameters is equivalent
to an LD design with k− 1 parameters if the linear parameter in the
two composed models is a nuisance parameter. Assorted examples of
LD designs are presented.
1. Introduction. A class of models is constructed by plugging a pharma-
cokinetic (PK) compartmental model into a pharmacodynamic (PD) Emax
model. Under this class of models, only one measurement is required per
study subject rather than multiple measurements and both PK and PD pa-
rameters can be estimated by a single experimental setup. Other advantages
of this approach will be listed shortly after the related PK and PD models
are introduced.
A basic PD Emax model can be expressed as E([D]) = E0 + Emax[D]/
(ED50+ [D]), where E(·) is the drug effect such as reduction in low-density
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cholesterol and [D] is the concentration of free drug in the environs of the
drug receptor. The Emax model contains three PD parameters. ED50 is the
drug concentration showing 50% of the maximum drug effect, Emax is the
maximum drug effect and E0 is the baseline effect. For the concept of Emax
model, the reader is referred to Ritschel [22]. Various applications of Emax
models have been discussed by, but are not limited to, Graves et al. [7],
Demana et al. [4], Angus et al. [1], Staab et al. [26] and Hedayat, Yan and
Pezzuto [11, 12].
Since a PK compartmental model describes drug concentration across
time, the [D] can be approximated by an appropriate PK model. After
replacing [D] in the Emax model by an open one-compartment model with
IV bolus input and first-order elimination results in the composed Emax-
PK1 model
Ytj = β0 +
β1 ·D
β2eβ3t +D
+ εtj ,(1.1)
where Ytj is the effect of the drug at time t observed on subject j, β0 is the
minimum residual effect, β1 is the maximum drug effect, β2 is the ED50 and
β3 is the total elimination rate. It is assumed that the errors across time and
subjects are i.i.d. N(0, σ2). Throughout this paper, D is the administered
dose in the unit of drug amount per unit body weight. For the concept
and essential results of the one-compartment model related to IV bolus,
the reader is referred to Rowland and Tozer [24], Landaw [16], Dette and
Neugebauer [5], Han and Chaloner [8] and Hedayat, Zhong and Nie [10].
If [D] is replaced by an open one-compartment model with the first-order
input and the first-order elimination, the resulting composed Emax-PK2
model becomes
Ytj = β0 +
β1 ·D(e
−β2t − e−β3t)
β4(1− β3β
−1
2 ) +D(e
−β2t − e−β3t)
+ εtj ,(1.2)
where β0 is the baseline effect, β1 is Emax, β2 is the absorption rate, β3 is the
total elimination rate and β4 is the ED50. The assumption about the error
terms is the same as that in model (1.1). For the concept and various results
related to this one-compartment model, the reader is referred to Rodda,
Sampson and Smith [23], Davidian and Gallant [3], Mallet [18], Mandema,
Verotta and Sheiner [19], Verme et al. [27], Lindsey et al. [17], Landaw [16],
Atkinson et al. [2] and Wakefield [28].
Other advantages of the Emax-PK models include (1) The PK parameters
can be estimated without drawing blood samples. (2) Drug effect becomes a
function of time rather than a function of drug concentration which itself is a
function of time. As a result, the drug effect is predictable across time, such
as blood pressure is being reduced across time. (3) Sampling at various time
points is controllable before taking samples, whereas the drug concentration
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in an Emax model alone is unknown before sampling. Therefore, one can
obtain better estimates of PK and PD parameters by implementing suitable
designs. (4) The residual effect of a drug can be estimated at any time point
through the Emax-PK1 model. (5) The baseline effect of a drug can be
estimated through the Emax-PK2 model.
In this paper, locally D-optimal (LD) designs and robust LD designs for
the preceding two Emax-PK models are studied for the purpose of estimat-
ing all population PK parameters. These PK parameters are considered fixed
effects although they likely differ between subjects. In Section 2, the equiv-
alence theory for nonlinear models is briefly reviewed. Section 3 contains
the main results about the number of sampling time points in an LD design
support for the Emax-PK models. Examples of LD designs for both models
are provided in Section 4. Some assorted robust LD designs are investigated
in Section 5. Discussion and conclusion are summarized in Section 6.
2. Preliminaries. The equivalence theorem for designs based on linear
models was first introduced and developed by Kiefer and Wolfowiz [15].
White [29] extended the equivalence theorem to locally optimal designs
based on nonlinear models. In a nonlinear model, the Fisher information
matrix depends on unknown parameters. As a result, there is no global op-
timization for all values of model parameters and the optimality of a design
can be evaluated only for special values of model parameters, called nomi-
nal or postulated values. For details, the reader is referred to Silvey [25] and
Hedayat [13].
Without loss of generality, let us consider the nonlinear model Ytj =
η(t, ~β) + εtj with εtj ’s being i.i.d. N(0, σ
2). The normalized Fisher infor-
mation matrix for the entire model parameters based on the design measure
ξ = {(t1, p1), . . . , (tK , pK)} can be expressed as
M(ξ, ~β) = σ−2
K∑
i=1
pi
(
∂η(ti, ~β)
∂~β
)(
∂η(ti, ~β)
∂~β
)′
.(2.1)
A design measure ξ = {(t1, p1), . . . , (tK , pK)} is a description of sampling
time points (t1, . . . , tK) where Ytij will be measured for the jth subject at
time ti. Associated with ti is the mass pi such that 0< pi < 1, and
∑
pi = 1.
In design ξ, p1, . . . , pK represent the proportion of the number of subjects
studied taken at time t1, . . . , tK , respectively. For a total sample of size n,
ni = npi is the number of subjects to be studied at ti. For the purpose of
obtaining the most precise estimators of the entire model parameters, one
needs to identify a design measure whose related Fisher information matrix
is nonsingular and whose determinant is maximized in the class of competing
designs. This is becauseM−1(ξ, ~β) is proportional to the asymptotic variance
and covariance matrix of the MLE of the model parameters. An LD design
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for a given set of parameters has the maximum determinant for its Fisher
information matrix based on the postulated values for these parameters.
When the number of PK parameters of interest is s≤ k in a k-parameter
nonlinear model, the asymptotic generalized variance of these s estimators
can be expressed as n−1[M(ξ, ~β)/M22(ξ, ~β)]
−1, where(
M11(ξ, ~β) M12(ξ, ~β)
M21(ξ, ~β) M22(ξ, ~β)
)
is the partitioned form of M(ξ, ~β) with M11(ξ, ~β) being the associated s×
s information matrix of the s parameters under the design ξ. Following
White [29], the design ξ∗ in a class of competing designs, D, is said to be an
LDs design if detM(ξ
∗, ~β)/detM22(ξ
∗, ~β) =maxξ∈D[detM(ξ, ~β)/detM22(ξ, ~β)].
White [29] established that the design ξ∗ is an LDs design if and only if
supt∈T d(t, ξ
∗, ~β) = s, where d(t, ξ, ~β) = tr{I(t, ~β)M−1(ξ, ~β)} − tr{I22(t, ~β)×
M−122 (ξ,
~β)} when s < k and d(t, ξ, ~β) = tr{I(t, ~β)M−1(ξ, ~β)} when s= k and
T = [0,∞) is the set of all sampling time points with the understanding that
the extreme right time point is a very large practitioner-selected time point.
Here, I(t, ~β) is the information matrix for the design with the support point
of t only and it is partitioned as that of M(ξ, ~β). The quantity d(t, ξ, ~β) can
be interpreted as the variance of the estimated response at time t when s= k
and is the variance of the estimated response after eliminating the effects of
the k− s nuisance parameters when s < k.
Before searching for optimal ti and pi, the required number of design
points in an LD design support is investigated first for both theoretical and
practical interests. Knowing the required number of design points in advance
would significantly reduce the task of searching for an LD design.
3. Main results. In this section, the support size of an LD design for the
Emax-PK1 model under the normality assumption is investigated. Since the
corresponding induced design space, C = {σ−1(∂η(t,
~β)
∂~β
) : t ∈ T }, is a bounded
subset in Rk and the determinant of the Fisher information matrix is a
continuous function on C, thus an LD design for this setup must exist. In
what follows, by a saturated design it is meant a design in which the number
of design time points is equal to the number of model parameters.
Theorem 1. Under model (1.1): E(Yt) = β0+
β1·D
β2e
β3t+D
with Var(Yt) =
σ2, where t ∈ [0, u], an LD design ξ∗ is a saturated D-optimal design with
time 0 and u in its support.
Proof. LetM(ξ∗, ~β) be the Fisher information matrix for ~β = (β0, β1, β2,
β3)
T based on an LD design ξ∗ and define f0(t) = tr(I(t, ~β)M
−1(ξ∗, ~β)) + c,
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where c ∈R is arbitrary and
I(t, ~β) = σ−2


1
D(β2e
β3t +D)−1
−β1De
β3t(β2e
β3t +D)−2
−β1Dβ2te
β3t(β2e
β3t +D)−2


×


1
D(β2e
β3t +D)−1
−β1De
β3t(β2e
β3t +D)−2
−β1Dβ2te
β3t(β2e
β3t +D)−2


T
.
It can be shown that f0(t) has the same number of zeros as f(t) = a40e
4β3t+
e3β3t(a31t+a30)+ e
2β3t(a22t
2+a21t+a20)+ e
β3t(a11t+a10)+a00, where aij
depends on ξ∗,D and βk, i ∈ {0,1,2,3,4}, j ∈ {0,1,2}, k ∈ {1,2,3}. No-
tice that a22 > 0 and a31 < 0 since the cofactor Cof14 in M
−1 is positive
(Appendix). Also, by the Remark in the Appendix, it can be shown that
a11 > 0. Now in order to prove that f(t) has at most six zeros, the proper-
ties of various derivatives of f(t) will be explored.
By differentiating f(t) with respect to t, one has
f ′(t) = 4β3a40e
4β3t + e3β3t(3β3a31t+ b30)
+ e2β3t(2β3a22t
2 + b21t+ b20) + e
β3t(β3a11t+ b10),
where the bij ’s are the corresponding constants. After setting f
′(t) = 0 and
multiplying both sides of f ′(t) = 0 by e−4β3t, one obtains
f˜ ′(t) = 4β3a40 + e
−β3t(3β3a31t+ b30) + e
−2β3t(2β3a22t
2 + b21t+ b20)
+ e−3β3t(β3a11t+ b10).
Notice that f ′(t) and f˜ ′(t) have the same number of zeros. After differenti-
ating f˜ ′(t), one has
f˜ ′′(t) = e−β3t(−3β23a31t+ c30) + e
−2β3t(−4β23a22t
2 + c21t+ c20)
+ e−3β3t(−3β23a11t+ c10),
where cij ’s are the corresponding constants. By multiplying f˜
′′(t) by e3β3t,
one has
˜˜
f ′′(t) = e2β3t(−3β23a31t+ c30)
+ eβ3t(−4β23a22t
2 + c21t+ c20) + (−3β
2
3a11t+ c10).
Differentiating
˜˜
f ′′(t) yields
˜˜˜
f ′′′(t) = e2β3t(−6β33a31t+ d30) + e
β3t(−4β33a22t
2 + d21t+ d20)− 3β
2
3a11,
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where dij ’s are the corresponding constants. Next, it will be shown that the
function
g(t) = e2β3t(−6β33a31t+ d30) + e
β3t(−4β33a22t
2 + d21t+ d20)
has at most three stationary points. By multiplying both sides of g′(t) = 0
by e−2β3t, one has
g˜′(t) =−12β43a31t+ e30 + e
−β3t(−4β43a22t
2 + e21t+ e20) = 0,
where eij ’s are the corresponding constants. Setting g˜
′′(t) = 0, one has
e−β3t(4β53a22t
2 + f21t+ f23) = 12β
4
3a31,(3.1)
where fij ’s are the corresponding constants. Since the left-hand side of (3.1)
has at most two stationary points and it approaches 0 above the t axis as t
goes to ∞, the most right monotone interval of the left-hand side will not
intersect the horizontal line y = 12β43a31, which is below the t axis. Therefore,
(3.1) has at most two roots.
Now, since (3.1) has at most two roots, g˜′(t) will have at most three zeros.
This implies that g(t) has at most three stationary points. Since g(t) goes to
0 below the t axis as t goes to −∞ and 3β23a11 > 0, the most left monotone
interval will not intersect the horizontal line y = 3β23a11, which is above the
t axis. Consequently,
˜˜˜
f ′′′(t) has at most three zeros. This implies that f˜ ′′(t)
has at most four zeros and f ′(t) has at most five zeros. As a result, f(t) has
at most six zeros.
Since f(t) has at most six zeros for all c′s and by the equivalence theorem
the interior points of an LD design must be locally maximum points of
tr(I(t, ~β)M−1(ξ∗, ~β)), therefore there are at most two optimal design points
on (0,∞). Otherwise, f(t) has more than six zeros for some c. Since the
induced design point at time 0 is not proportional to that at time u > 0,
the existence of an LD design based on model (1.1) forces the two boundary
points to be in the optimal design support. 
Theorem 1 demonstrates that an LD design for model (1.1) is of the
form ξ∗ = {(0,1/4), (t2 ,1/4), (t3,1/4), (u,1/4)} over t ∈ [0, u]. Consequently,
to search for an LD design for model (1.1), one only needs to find out t2 and
t3.
Theorem 2. An LD design for the Emax-PK2 model has minimum
support size with time point 0 in its support if d(t, ξ, ~β) has precisely four
locally maximum time points when t ∈ (0,∞).
Proof. By Carathe´odory’s theorem [25], for this five-parameter nonlin-
ear model, an LD design must have at least five time points in its support.
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By the equivalence theorem, LD design time points must be necessarily the
locally maximum points of d(t, ξ, ~β) when t ∈ (0,∞). Since d(t, ξ, ~β) has four
locally maximum time points and the induced design time points at t= 0
and t=∞ are the same, the existence of an LD design forces time point 0
and the four locally maximum points to be in the design support. 
Theorem 2 provides a sufficient condition for an LD design for the Emax-
PK2 model to be minimally supported when the original design space is
[0,∞). In general, if the required number of LD sampling time points is un-
known for a k-parameter nonlinear model, the practitioner could search for
the best k-point uniform LD design first. Then the V-algorithm by Fedorov
[6] can be applied to search for an LD design with the k-point uniform LD
design as the initial design.
When β0 is a nuisance parameter, it is found that an LD design is also
an LDk−1 design for a k-parameter nonlinear model of the form ytj = β0 +
η˜(t, ~β) + εtj , where εtj are i.i.d. N(0, σ
2) and ∂η˜(t, ~β)/∂βi is not free of βi
for i= 1, . . . , k−1. For a model of this form, the following result is obtained.
Theorem 3. An LD design for the k-parameter nonlinear model is also
an LDk−1 design for parameters β1, . . . , βk−1.
The proof is based on the fact that both I22 in I(t, ~β) andM
−1
22 inM(ξ
∗, ~β)
are equal to 1. Theorem 3 shows that the LDk−1 design is globally optimized
for β0 although it is only locally optimal for the other nonlinear parameters.
Theorem 3 is applicable to both Emax-PK models discussed in this paper.
Examples of LDk−1 designs originated from LD designs for both Emax-PK1
and Emax-PK2 models are given in Section 4.
4. Illustrated examples. Maximizing the determinant of the Fisher in-
formation matrix under nonlinear models requires the foreknowledge of the
values of model parameters. In practice, a good guess can be obtained from
a pilot experiment. For example, suppose based on the prior information
from the pilot experiment, the minimum residual effect is equal to 0.5, the
maximum drug effect is equal to 10, the ED50 is equal to 1 mg/kg and the
total elimination rate is equal to 0.1 hour−1. The search for an LD design
generally contains two steps: (1) finding a best k-point uniform LD design;
(2) using the V-algorithm (Fedorov [6]) to find an LD design given the ini-
tial design as that found in step (1). For the Emax-PK2 model, a search
as described was performed. However, for the Emax-PK1 model, the search
was stopped at step (1) since Theorem 1 shows that an LD design for this
model is a saturated LD design.
For the Emax-PK1 model with postulated ~β = (0.5,10,1,0.1) and an ini-
tial dose of 5 mg/kg, a four-point LD design is found to be uniform at
8 X. FANG AND A. S. HEDAYAT
times 0, 13.48, 31.62 and 160.00 hours. Figure 1 illustrates some essential
characteristics of d(t, ξ, ~β) for this design.
If the maximum sampling time is 72 or 24 hours, then the LD design can
be found to be uniform at times 0, 13.26, 31.05 and 72 hours or at times
0, 7.97, 17.83 and 24 hours, respectively. The d(t, ξ, ~β) for these two designs
are illustrated in Figures 2 and 3.
Although the upper bound of the support size for an LD design based
on the Emax-PK2 model is 16 by Carathe´odory’s theorem, one can still
follow the two-step search described above. For the Emax-PK2 model with
postulated ~β = (0.5,10,0.5,0.1,1), an LD design is found to be uniform at
Fig. 1. Plots of d(t, ξ∗, ~β) with (a) t ∈ [0,20] and (b) t ∈ [20,200], respec-
tively. The design space is [0,∞) and the optimal sampling times are found at
0,13.481506,31.624511,160.00199. The initial IV dose is 5 mg/kg.
Fig. 2. Plots of d(t, ξ∗, ~β) with (a) t ∈ [0,20] and (b) t ∈ [20,200], respectively.
The design space is [0,72] hours and the optimal sampling times are found to be at
0,13.263029,31.050686 and 72 hours.
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times 0, 0.275, 2.999, 14.75 and 32.7 hours. The associated d(t, ξ, ~β) for this
design is illustrated in Figure 4.
5. Robust designs. Applying an LD design in practice may be criticized
for its local optimality. If the nominal values of the model parameters are not
close to the true values, a more desirable design would be a robust design,
which would lead to a better parameter estimation than an LD design while
maintaining high efficiency. The relative efficiency of a design ξ compared
to an LD design ξ∗ for the postulated ~β is defined as det (ξ, ~β)/det (ξ∗, ~β).
A robust index defined as |(∂(detM(ξ, ~β))/∂βi)
−1| for parameter βi, i=
0,1, . . . is introduced to compare the robustness of LD designs based on
different nominal values of the model parameters. For a linear model, this
robust index is ∞, indicating that an LD design is globally optimal for all
values of the model parameters. However, for a nonlinear model, it measures
the inverse of the changing rate of the determinant in the neighborhood of
the postulated ~β. Therefore, it is called the locally robust index (LRI). The
larger the value of the LRI, the more locally robust the design.
One class of robust designs is the equally spaced uniform LD (ESULD)
designs. An advantage of this class of designs is that it can be implemented
very easily. It is robust for the estimation of parameters in the models that
were described in Hedayat, Yan and Pezzuto [11, 12] and Hedayat, Zhong
and Nie [10]. The class of ESULD designs is examined here for both Emax-
PK1 and Emax-PK2 models. Table 1 shows that an ESULD design retains its
robustness but loses its efficiency as the size of the design support increases.
For practical applications, the five- or the six-point ESULD designs are
recommended.
Since the efficiency of the ESULD designs is very low for the Emax-PK2
model, another class of robust designs is constructed based on an LD design.
Fig. 3. Plot of d(t, ξ∗, ~β) when the design space is [0,24] hours based on the Emax-PK1
model.
1
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Table 1
ESULD designs for the model with the initial dose= 5 mg/kg and the nominal values β1 = 10, β2 = 1 mg/kg, β3 = 0.1 h
−1
Support size Support of ξ Efficiency of ξ LRI for β1 LRI for β2 LRI for β3
4 0,13.48,31.62,160.00 1 0.95901654 0.10344687 0.019187232
5 0,16.176× i, i= 1,2,3,4 0.476373989 2.0131589 0.19911378 0.040256987
6 0,14.736× i, i= 1,2,3,4,5 0.481038755 1.9936368 0.20439842 0.039876038
7 0,13× i, i= 1,2, . . . ,6 0.440686613 2.1761871 0.22903063 0.043844867
8 0,11.094× i, i= 1,2, . . . ,7 0.403119466 2.3789884 0.25133456 0.047580261
9 0,9.647× i, i= 1,2, . . . ,8 0.376132417 2.549678 0.26807298 0.050989122
10 0,8.558× i, i= 1,2, . . . ,9 0.355042847 2.701129 0.28268401 0.054018207
11 0,7.686× i, i= 1,2, . . . ,10 0.3379349 2.8378736 0.29572619 0.056762451
12 0,7× i, i= 1,2, . . . ,11 0.323818285 2.9615886 0.30723535 0.058653795
When s= 4, the design is the LD design.
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Fig. 4. Plots of d(t, ξ∗, ~β) with (a) t ∈ [0,0.5], (b) t ∈ [0.5,20], (c) t ∈ [20,60] and (d)
t ∈ [60,200], respectively. The numerical solutions of the local maximums are 0, 0.275,
2.999, 14.75, 32.695. The initial dose is 5 mg/kg.
The support of such a robust design includes all the design time points of
an LD design as well as the design time points in the form of t∗+ r or t∗− r,
where t∗ is a design time point of an LD design and r is a fixed number.
For convenience, this class of designs is referred to as equal-step expanded
uniform LD (ESEULD) designs. For example, if an LD design is
ξ∗ =
(
t1 t2 t3
1/3 1/3 1/3
)
,
then a four-point ESEULD design would be
ξ∗∗ =
(
t1 t1 + r t2 t3
1/4 1/4 1/4 1/4
)
;
a five-point ESEULD design would be
ξ∗∗ =
(
t1 t1 + r t2 t2 + r t3
1/5 1/5 1/5 1/5 1/5
)
;
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Fig. 5. The efficiency of a ESEULD design versus step length r based on (a) Emax-PK1
model and (b) Emax-PK2 model.
a six-point ESEULD design would be
ξ∗∗ =
(
t1 t1 + r t2 t2 + r t3 − r t3
1/6 1/6 1/6 1/6 1/6 1/6
)
and a seven-point ESEULD design would be
ξ∗∗ =
(
t1 t1 + r t2 − r t2 t2 + r t3 − r t3
1/7 1/7 1/7 1/7 1/7 1/7 1/7
)
.
Since the relative efficiency of the design ξ∗∗ relative to an LD design ξ∗,
detM(ξ∗∗, ~β)/detM(ξ∗, ~β), is a function of r given ξ∗ and ~β, it is impossible
to give an explicit form of r as a function of efficiency. However, it is possible
to plot efficiency versus step length r to find out the numerical relationship
between r and the efficiency. Figure 5(a) and 5(b) shows such plots based
on the Emax-PK1 model and the Emax-PK2 model, respectively. The same
postulated values of βi’s as those in Section 4 are used for illustrations and
tables throughout this section. From this figure, it is clear that the value
of r cannot be assigned arbitrarily for some n-point ESEULD designs. For
example, r = 0.95 does not exist for a five-point ESEULD design based
on the Emax-PK1 model. In this figure, r = 1 hour and r = 0.2 hour are
chosen for robustness study based on the Emax-PK1 model and the Emax-
PK2 model, respectively. The corresponding design time points are listed in
Tables 2 and 3. The LRI’s are calculated and listed in Tables 4 and 5. From
these results, it appears that the higher the relative efficiency of a robust
LD design, the less the robustness of the design.
6. Conclusion and discussion. This paper introduced a class of models
by blending a PD Emax model and a PK compartmental model and studied
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some important features of LD, ESULD and ESEULD designs for the Emax-
PK1 and the Emax-PK2 models in this class.
For Emax-PK1 model, an LD design is a saturated four-point uniform
LD design with the two boundary time points of the design space in its
support. Both time 0 and the upper bound of the design space are the infor-
mative time points here. This can be observed directly from the model. As
t approaches ∞, the Emax-PK1 model is reduced to Ytj = β0 + εtj . There-
fore, the upper bound of the design space is an informative time point for
Table 2
ESEULD designs based on the Emax-PK1 model with r= 1 hour
Support size ESEULD design point
4 0,13.48,31.62,160.00
5 0,1,13.48,31.62,160.00
6 0,1,13.48,14.48,31.62,160.00
7 0,1,13.48,14.48,31.62,32.62,160.00
8 0,1,13.48,14.48,31.62,32.62,159,160.00
9 0,1,12.48,13.48,14.48,31.62,32.62,159,160.00
10 0,1,12.48,13.48,14.48,30.62,31.62,32.62, 159,160.00
Table 3
ESEULD designs based on the Emax-PK2 model with r = 0.2 hour
Support size ESEULD design points
5 0,0.275,2.999,14.75,32.695
6 0,0.275,0.475,2.999,14.75,32.695
7 0,0.275,0.475,2.999,3.199,14.75, 32.695
8 0,0.275,0.475,2.999,3.199,14.75, 14.95, 32.695
9 0,0.275,0.475,2.999,3.199,14.75, 14.95, 32.495,32.695
10 0,0.275,0.475,2.799,2.999,3.199, 14.75, 14.95, 32.495,32.695
Table 4
Efficiency and robustness of ESEULD designs for the Emax-PK1 model
ESEULD design Efficiency of ξ LRI: β1 LRI: β2 LRI: β3
4-point 1 0.95901654 0.10344687 0.019187232
5-point 0.7588 1.2638471 0.135847 0.025576467
6-point 0.7284 1.3165725 0.13967382 0.025674003
7-point 0.7846 1.2223363 0.12857595 0.021936078
8-point 0.9193 1.0431845 0.10970443 0.018685843
9-point 0.8583 1.1172873 0.1190755 0.020901414
10-point 0.8437 1.1366831 0.12194774 0.022945661
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Table 5
Efficiency and robustness of ESEULD designs for the Emax-PK2 model
ESEULD
design Efficiency of ξ LRI: β1 LRI: β2 LRI: β3 LRI: β4
5-point 1 0.3067854 0.046489413 0.0090373459 0.043066663
6-point 0.7667 0.40014335 0.055507767 0.011777852 0.058844405
7-point 0.6995 0.43857707 0.059457229 0.013001578 0.064883822
8-point 0.7168 0.42799782 0.05768681 0.012643369 0.063180006
9-point 0.7952 0.38580638 0.052011575 0.011571927 0.057033582
10-point 0.6995 0.4385802 0.059583199 0.013097578 0.064855939
parameter β0. When t= 0, the model is reduced to Ytj = β0 +
β1D
β2+D
+ εtj .
Consequently, time 0 is an informative time point for β0 as well as the ratio
of β1/β2.
A sufficient condition for the Emax-PK2 model to be minimally supported
is given. Time 0 is an informative time point here. This also can be explained
from the Emax-PK2 model directly. As time goes to 0, the Emax-PK2 model
is reduced to Ytj = β0 + εtj .
When β0 is considered as a nuisance parameter, an LD design and an
LDk−1 design based on any of the Emax-PK models are equivalent. The
corresponding LD design is globally optimal for the linear parameter β0 and
locally optimal for the other nonlinear parameters.
Future research for the Emax-PK models could involve random effects for
certain PK parameters since these parameters likely differ between subjects.
The reader is referred to Mentre, Mallet and Baccar [20], Palmer and Muller
[21], Han and Chaloner [9] for recent results in this area.
APPENDIX: PROOFS
Cof14 of M(ξ
∗, ~β)−1 is positive and Cof24 of M(ξ
∗, ~β)−1 is negative.
Since the Fisher information matrix of ~β = (β0, β1, β2, β3)
T at sampling
time ti for an LD design ξ
∗ =
( t1 t2 ... ts
p1 p2 ... ps
)
based on model (1.1) or the
Emax-PK1 model is
I(ti, ~β) = σ
−2pi


1
D(β2e
β3ti +D)−1
−β1De
β3ti(β2e
β3ti +D)−2
−β1Dβ2tie
β3ti(β2e
β3ti +D)−2


×


1
D(β2e
β3ti +D)−1
−β1De
β3ti(β2e
β3ti +D)−2
−β1Dβ2tie
β3ti(β2e
β3ti +D)−2


T
,
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the Cof14 has the same sign as
−detm14 =−det


s∑
i=1
pi
D
(β2eβ3ti +D)
s∑
i=1
pi
D2
(β2eβ3ti +D)2
s∑
i=1
pi
−D2β1e
β3ti
(β2eβ3ti +D)3
s∑
i=1
pi
−Dβ1e
β3ti
(β2eβ3ti +D)2
s∑
i=1
pi
−D2β1e
β3ti
(β2eβ3ti +D)3
s∑
i=1
pi
D2β21e
2β3ti
(β2eβ3ti +D)4
s∑
i=1
pi
−Dβ1β2tie
β3ti
(β2eβ3ti +D)2
s∑
i=1
pi
−D2β1β2tie
β3ti
(β2eβ3ti +D)3
s∑
i=1
pi
D2β21β2tie
2β3ti
(β2eβ3ti +D)4


.
Let
g(ti, tj , tk) = det


D
(β2eβ3ti +D)
D2
(β2eβ3tj +D)2
−D2β1e
β3tk
(β2eβ3tk +D)3
−Dβ1e
β3ti
(β2eβ3ti +D)2
−D2β1e
β3tj
(β2eβ3tj +D)3
D2β21e
2β3tk
(β2eβ3tk +D)4
−Dβ1β2tie
β3ti
(β2eβ3ti +D)2
−D2β1β2tje
β3tj
(β2eβ3tj +D)3
D2β21β2tke
2β3tk
(β2eβ3tk +D)4


∀i < j < k ≤ s, then the determinant of m14 is detm14 =∑
i<j<k≤s
∑
permutations of i ,j ,k pipjpkg(ti, tj, tk).
Now without loss of generality, let i= 1, j = 2, k = 3; then it can be shown
that ∑
permutations of 1,2,3
g(t1, t2, t3) =−
D7β31β
3
2
(β2eβ3t1 +D)4(β2eβ3t2 +D)4(β2eβ3t3 +D)4
×
∣∣∣∣∣∣
1 eβ3t1 t1e
β3t1
1 eβ3t2 t2e
β3t2
1 eβ3t3 t3e
β3t3
∣∣∣∣∣∣
∣∣∣∣∣∣
1 eβ3t1 e2β3t1
1 eβ3t2 e2β3t2
1 eβ3t3 e2β3t3
∣∣∣∣∣∣ ,
since
g(t1, t2, t3) =−
D6β31β2
(β2eβ3t1 +D)4(β2eβ3t2 +D)4(β2eβ3t3 +D)4
∣∣∣∣∣∣
1 eβ3t1 t1e
β3t1
1 eβ3t2 t2e
β3t2
1 eβ3t3 t3e
β3t3
∣∣∣∣∣∣
× (β2e
β3t1 +D)2(β2e
β3t2 +D)eβ3t3 .
Now since both {1, eβ3t, teβ3t} and {1, eβ3t, e2β3t} are Chebyshev systems (see
Karlin and Studden [14]) and their determinants are positive,∑
permutations of 1,2,3 g(t1, t2, t3) < 0. Therefore, detm14 =∑
i<j<k≤s
∑
permutations of i ,j ,k pipjpkg(ti, tj, tk) < 0. This implies that the
Cof14 > 0.
Next, Cof24 < 0 will be shown. By the same argument, it can be proved
that
Cof24 =
∑
i<j<k≤s
pipjpkQ
∣∣∣∣∣∣
1 ti tie
β3ti
1 tj tje
β3tj
1 tk tke
β3tk
∣∣∣∣∣∣
∣∣∣∣∣∣
1 eβ3ti e2β3ti
1 eβ3tj e2β3tj
1 eβ3tk e2β3tk
∣∣∣∣∣∣−Cof14,
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where
Q=−
D5β31β
5
2e
β3(ti+tj+tk)
(β2eβ3ti +D)4(β2eβ3tj +D)4(β2eβ3tk +D)4
.
Since {1, t, eβ3t} is a Chebyshev system (see Karlin and Studden [14]) and
Cof14 > 0, this yields Cof24 < 0.
Remark.
−Cof14 −Cof24 =−
∑
i<j<k≤s
pipjpkQ
∣∣∣∣∣∣
1 ti tie
β3ti
1 tj tje
β3tj
1 tk tke
β3tk
∣∣∣∣∣∣
∣∣∣∣∣∣
1 eβ3ti e2β3ti
1 eβ3tj e2β3tj
1 eβ3tk e2β3tk
∣∣∣∣∣∣ ,
which is positive.
Acknowledgments. The authors are grateful for the many valuable com-
ments and suggestions provided by the Associate Editor and the three refer-
ees who critically evaluated the original submission. The authors also thank
Professor Bikas K. Sinha for his valuable inputs while the authors were ex-
ploring this line of research.
REFERENCES
[1] Angus, B. J., Thaiaporn, I., Chanthapadith, K., Suputtamongkol, Y. and
White, N. J. (2002). Oral artesunate dose-response relationship in acute falci-
parum malaria. Antimicrobial Agents and Chemotherapy 46 778–782.
[2] Atkinson, A. C., Chaloner, K., Herzberg, A. M. and Juritz, J. (1993). Optimal
experimental designs for properties of a compartmental model. Biometrics 49
325–337.
[3] Davidian, M. and Gallant, A. (1992). Smooth nonparametric maximum likelihood
estimation for population pharmacokinetics, with application to Quinidine. J.
Pharmacokinetics and Biopharmaceutics 20 529–556.
[4] Demana, P., Smith, E., Walker, R., Haigh, J. andKanfer, I. (1997). Evaluation
of the proposed FDA pilot dose-response methodology for topical corticosteroid
bioequivalence testing. Pharmaceutical Research 14 303–308.
[5] Dette, H. and Neugebauer, H.-M. (1997). Bayesian D-optimal designs for expo-
nential regression models. J. Statist. Plann. Inference 60 331–349. MR1456635
[6] Fedorov, V. V. (1972). Theory of Optimal Experiments. Academic Press, New York.
MR0403103
[7] Graves, D., Muir, K., Richards, W., Steiger, B., Chang, I. and Patel, B.
(1990). Hydralazine dose-response curve analysis. J. Pharmacokinetics and Bio-
pharmaceutics 18 279–291.
[8] Han, C. and Chaloner, K. (2003). D- and c-optimal designs for exponential regres-
sion models used in viral dynamics and other applications. J. Statist. Plann.
Inference 115 585–601. MR1985885
[9] Han, C. and Chaloner, K. (2004). Bayesian experimental design for nonlinear
mixed-effects models with application to HIV dynamics. Biometrics 60 25–33.
MR2043615
LD DESIGN FOR COMPOSED PK/PD MODELS 17
[10] Hedayat, A. S., Zhong, J. and Nie, L. (2004). Optimal and efficient designs
for 2-parameter nonlinear models. J. Statist. Plann. Inference 124 205–217.
MR2066235
[11] Hedayat, A. S., Yan, B. and Pezzuto, J. M. (2002). Optimum designs for esti-
mating EDp based on raw optical density data. J. Statist. Plann. Inference 104
161–174. MR1900524
[12] Hedayat, A. S., Yan, B. and Pezzuto, J. M. (1997). Modeling and identifying
optimum designs for fitting dose-response curves based on raw optical density
data. J. Amer. Statist. Assoc. 92 1132–1140. MR1482144
[13] Hedayat, A. (1981). Study of optimality criteria in design of experiments. In Statis-
tics and Related Topics (M. Csorgo, D. A. Dawson, J. N. K. Rao and A. K. M.
E. Saleh, eds.) 39–56. North-Holland, Amsterdam. MR0665266
[14] Karlin, S. and Studden, W. J. (1966). Tchebyscheff Systems: With Applications
in Analysis and Statistics. Wiley, New York. MR0204922
[15] Kiefer, J. and Wolfowitz, J. (1960). The equivalence of two extremum problems.
Cannid. J. Math. 12 363–366. MR0117842
[16] Landaw, E. M. (1980). Optimal experimental design for biological compartmen-
tal systems with applications to pharmacokinetics. Ph.D. dissertation, UCLA,
University Microfilms International.
[17] Lindsey, J. K., Byrom, W. D., Wang, J., Jarvis, P. and Jones, B. (2000).
Generalized nonlinear models for pharmacokinetic data. Biometrics 56 81–88.
[18] Mallet, A. (1992). A nonparametric method for population pharmacokinetics: A
case study. Amer. Statist. Assoc. Proceedings of the Biopharmaceutical Section
11–20.
[19] Mandema, J. W., Verotta, D. and Sheiner, L. (1992). Building population phar-
macokinetic pharmacodynamic models. I. Models for covariate effects. J. Phar-
macokinetics and Biopharmaceutics 20 511–528.
[20] Mentre, F., Mallet, A. and Baccar, D. (1997). Optimal design in random-effect
regression models. Biometrika 84 429–442. MR1467058
[21] Palmer, J. L. andMuller, P. (1998). Bayesian optimal design in population models
for haematologic data. Statistics in Medicine 17 1613–1622.
[22] Ritschel, W. A. (1992). Handbook of Basic Pharmacokinetics, 4th ed. Drug Intel-
ligence Publications, Inc.
[23] Rodda, B. E., Sampson, C. B. and Smith, D. W. (1975). The one-compartment
open model: Some statistical aspects of parameter estimation. Appl. Statist. 24
309–318.
[24] Rowland, M. and Tozer, T. N. (1995). Clinical Pharmacokinetics—Concepts and
Applications, 3rd ed. Philadelphia Lea and Febiger.
[25] Silvey, S. D. (1980). Optimal Design. Chapman and Hall, New York. MR0606742
[26] Staab, A., Tillmann, C., Forgue, S., Macie, A., Allerheiligen, S., Rapado,
J. and Troconiz, I. (2004). Population dose-response model for tadalafil in the
treatment of male erectile dysfunction. Pharmaceutical Research 21 1463–1470.
[27] Verme, C. N., Ludden, T. M., Clementi, W. A. and Harris, S. C. (1992).
Pharmacokinetics of quinidine in male patients. Clinical Pharmacokinetics 22
468–480.
[28] Wakefield, J. (1996). The Bayesian analysis of population pharmacokinetic models.
J. Amer. Statist. Assoc. 91 62–75.
[29] White, L. (1973). An extension of the general equivalence theorem to nonlinear
models. Biometrika 60 345–348. MR0326948
18 X. FANG AND A. S. HEDAYAT
Department of Mathematics,
Statistics, and Computer Sciences
University of Illinois
322 Science and Engineering Offices (M/C 249)
850 S. Morgan Street
Chicago, Illinois 60607-7045
USA
E-mail: hedayat@uic.edu
